PlainRecalls
FDA Drug Critical Class I Terminated

Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.

Reported: August 26, 2015 Initiated: March 23, 2015 #D-1333-2015

Product Description

Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.

Reason for Recall

Presence of Particulate Matter

Details

Recalling Firm
Mylan Institutional LLC
Units Affected
2,455 vials
Distribution
Nationwide and Puerto Rico
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.. Recalled by Mylan Institutional LLC. Units affected: 2,455 vials.
Why was this product recalled?
Presence of Particulate Matter
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2015. Severity: Critical. Recall number: D-1333-2015.